IIA
CTMX icon

IPG Investment Advisors’s CytomX Therapeutics CTMX Stock Holding History

IPG Investment Advisors’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.9K Hold
12,500
– – 0.01% 264
2026
Q1 		$58.8K Hold
12,500
– – 0.01% 236
2025
Q4 		$53.3K Hold
12,500
– – 0.01% 219
2025
Q3 		$39.9K Hold
12,500
– – 0.01% 211
2025
Q2 		$28.4K Hold
12,500
– – 0.01% 176
2025
Q1 		$7.95K Hold
12,500
– – ﹤0.01% 169
2024
Q4 		$12.9K Hold
12,500
– – ﹤0.01% 173
2024
Q3 		$14.8K Hold
12,500
– – ﹤0.01% 172
2024
Q2 		$15.3K Hold
12,500
– – ﹤0.01% 173
2024
Q1 		$27.3K Hold
12,500
– – 0.01% 165
2023
Q4 		$19.4K Buy
+12,500
New +$16.4K ﹤0.01% 189
2023
Q3 		– Sell
-12,500
Closed -$21.5K – 163
2023
Q2 		$21.5K Hold
12,500
– – ﹤0.01% 167
2023
Q1 		$18.9K Hold
12,500
– – ﹤0.01% 160
2022
Q4 		$20K Hold
12,500
– – 0.01% 134
2022
Q3 		$18.1K Hold
12,500
– – 0.01% 136
2022
Q2 		$23K Hold
12,500
– – 0.01% 150
2022
Q1 		$33K Hold
12,500
– – 0.01% 163
2021
Q4 		$55K Hold
12,500
– – 0.01% 198
2021
Q3 		$63.6K Hold
12,500
– – 0.02% 126
2021
Q2 		$79.1K Buy
+12,500
New +$97.3K 0.02% 135

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

IPG Investment Advisors's CTMX Position: Q2 2026 in Review

IPG Investment Advisors held its CytomX Therapeutics (CTMX) position steady in Q2 2026 at 12,500 shares worth $46.9K. The position accounts for 0.01% of the portfolio, ranked #264.

IPG Investment Advisors first reported a position in CTMX in Q2 2021 and has held it in 20 quarters since. The position peaked at $79.1K in Q2 2021. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • IPG Investment Advisors held 12,500 shares of CytomX Therapeutics worth $46.9K as of Q2 2026.
  • IPG Investment Advisors left its CytomX Therapeutics share count unchanged in Q2 2026.
  • CytomX Therapeutics made up 0.01% of IPG Investment Advisors's portfolio in Q2 2026, its #264 holding.
  • IPG Investment Advisors first reported a position in CytomX Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • IPG Investment Advisors's CytomX Therapeutics position peaked at $79.1K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on IPG Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.